Company page

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, trading under the ticker ADPT, is a public company based in the United States with a market capitalization of approximately $3.67 billion. The company specializes in utilizing its proprietary technology to analyze the immune system and develop diagnostic tools and therapies. Adaptive Biotechnologies focuses on advancing precision medicine through its innovative approaches to understanding and treating diseases.